EU Research Projects


New Call Round

Proposals inviting IBDIM Ltd.*(= Research Ltd. of ECCO) as project participant: 
Standard Operating Procedures (SOPs) for such project invitations can be requested from the ECCO Office by email: This email address is being protected from spambots. You need JavaScript enabled to view it.


Open calls  Upcoming EU Submisison Deadlines Deadline for project invitations to IBDIM

Two Stage Calls

1st deadline: October 24, 2018
2nd deadline: May 15 2019

IMI2-2018-15-01: Integrated research platforms enabling patient-centric drug development

IMI2-2018-15-02: Blockchain Enabled Healthcare

IMI2-2018-15-03: Microenvironment imposed signatures in tissue and liquid biopsies in immune-mediated diseases

IMI2-2018-15-04: Emerging translational safety technologies and tools for interrogating human immuno-biology

IMI2-2018-15-05: Development and validation of translational platforms in support of synaptopathy drug discovery

IMI2-2018-15-06: Digital endpoints in neurodegenerative and immune-mediated diseases

IMI2-2018-15-07: AMR Accelerator programme Pillar A: Capability Building Network to accelerate and validate scientific discoveries

6 weeks prior to 1st  stage 

Single Stage Calls 

Deadline: April 16, 2019

SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications

SCI-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis

SCI-BHC-13-2019: Mining big data for early detection of infeectious disease threats driven by climate change and other factors

SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health

SC1-BHC-31-2019: Pilot actions to build the foundations of a human cell atlas

SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine

SC1-HCO-15-2019: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)

Deadline: April 24, 2019

SC1-DTH-01-2019: Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment

SC1-DTH-05-2019: Large scale implementation of digital innovation for health and care in an ageing society

SC1-DTH-09-2019: Scaling up the univocal Identification of Medicinal Products

SC1-DTH-11-2019: Large Scale pilots of personalised & outcome based integrated care

SC1-HCC-02-2019: Support for the large scale uptake of open service platforms in the Active and Healthy Ageing domain

13 weeks prior to deadline 

(*) In great anticipation of Horizon 2020 opening up a new era of European research, ECCO founded IBDIM – IBD in Motion Ltd. (IBDIM) in January 2014 in order to facilitate European research projects in the field of IBD. Its core mission is to bundle scientific expertise and clinical research consultancy – particularly for EU projects and similar projects in cooperation with other partner institutions. Within this framework, IBDIM Ltd. can rely on the network of voluntary ECCO experts for its consulting, consensus, review, and dissemination processes.

CEO of IBDIM – IBD in Motion Ltd.

Dr Filip Baert
AZ Delta
Roeselare, Belgium
This email address is being protected from spambots. You need JavaScript enabled to view it.

Project Partner Search:


FP7 Sadel Project

Horizon 2020 - BIOCYCLE Project